English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Missouri researchers receive grants for innovative lung disease studies
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Health risks linked to incense burning highlighted at ACAAI meeting
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Iowa researcher receives grant for chronic airway disease study
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Dr. Huda Zoghbi honored by American Academy for her contributions to science
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

New studies reveal gaps in understanding severe allergic reaction treatments
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Quema de incienso podría afectar gravemente a personas con alergias o asma
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Study suggests reevaluation of penicillin allergy labels in syphilis treatment
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Zoghbi joins esteemed ranks at American Academy induction

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes